DrugPatentWatch Database Preview

Astrazeneca Pharms Company Profile

ASTRAZENECA PHARMS has twenty-three approved drugs.

There are seventy-eight US patents protecting ASTRAZENECA PHARMS drugs.

There are one thousand five hundred and twenty-six patent family members on ASTRAZENECA PHARMS drugs in sixty-eight countries and one hundred and thirty supplementary protection certificates in sixteen countries.

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astrazeneca Pharms	LOKELMA	sodium zirconium cyclosilicate	FOR SUSPENSION;ORAL	207078-002	May 18, 2018		RX	Yes	Yes	8,802,152	➤ Sign Up		Y		➤ Sign Up
Astrazeneca Pharms	BRILINTA	ticagrelor	TABLET;ORAL	022433-001	Jul 20, 2011	AB	RX	Yes	Yes	6,251,910	➤ Sign Up		Y		➤ Sign Up
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	021957-003	Dec 15, 2011		RX	Yes	No	6,369,085*PED	➤ Sign Up			Y	➤ Sign Up
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	021957-004	Dec 15, 2011		RX	Yes	No	6,369,085*PED	➤ Sign Up			Y	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	CAPSULE, DELAYED REL PELLETS;ORAL	021153-002	Feb 20, 2001	5,690,960*PED	➤ Sign Up
Astrazeneca Pharms	PRILOSEC OTC	omeprazole magnesium	TABLET, DELAYED RELEASE;ORAL	021229-001	Jun 20, 2003	5,753,265	➤ Sign Up
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	021957-002	Oct 20, 2006	5,690,960*PED	➤ Sign Up
Astrazeneca Pharms	NEXIUM	esomeprazole magnesium	FOR SUSPENSION, DELAYED RELEASE;ORAL	021957-003	Dec 15, 2011	5,690,960*PED	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release for Oral Suspension	2.5 mg and 5 mg	➤ Subscribe	2018-09-24
➤ Subscribe	Nasal Spray	250 mcg	➤ Subscribe	2012-02-13
➤ Subscribe	Inhalation Suspension	1 mg/2 mL	➤ Subscribe	2010-05-28
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2012-03-30
➤ Subscribe	Tablets	60 mg	➤ Subscribe	2015-09-30
➤ Subscribe	Tablets	12.5 mg and 25 mg	➤ Subscribe	2018-09-17
➤ Subscribe	Tablets	50 mg, 150 mg and 400 mg	➤ Subscribe	2007-02-12
➤ Subscribe	Delayed-release	20 mg and 40 mg	➤ Subscribe	2005-08-05
➤ Subscribe	For Injection	20 mg/vial and 40 mg/vial	➤ Subscribe	2009-11-23
➤ Subscribe	Inhalation Suspension	0.25 mg/2 mL and 0.5 mg/2 mL	➤ Subscribe	2005-09-15
➤ Subscribe	Delayed-release Capsules	20 mg	➤ Subscribe	2007-03-19
➤ Subscribe	Tablets	90 mg	➤ Subscribe	2015-07-20
➤ Subscribe	Tablets	500 mcg	➤ Subscribe	2015-03-02
➤ Subscribe	Tablets	25 mg	➤ Subscribe	2005-08-12
➤ Subscribe	Tablets	100 mg, 200 mg and 300 mg	➤ Subscribe	2006-02-21

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
90006-4	Sweden	➤ Sign Up	PRODUCT NAME: ACETYLSALICYLSYRA OCH ESOMEPRAZOLMAGNESIUMTRIHYDRAT; NAT. REG. NO/DATE: MTNR 44371 20110930; FIRST REG.: PT 5402359MFL 20110812
2011 00013	Denmark	➤ Sign Up	PRODUCT NAME: TICAGRELOR ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF
C0016	France	➤ Sign Up	PRODUCT NAME: TICAGRELOR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE IN FRANCE: EU/1/10/655/001 DU 20101203; REGISTRATION NO/DATE AT EEC: EU/1/10/655/001-006 DU 20101203
C0005	Belgium	➤ Sign Up	PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.